Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Articaine versus lidocaine as supplemental intraligamentary anesthesia after failed mandibular nerve block
IRCT2015100523253N2Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of articaine and lidocaine in irreversible pulpitis (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Anesthetic efficacy. Started Oct 2016; status: completed.
02
Drugs
articainelidocaine
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on IRCT2015100523253N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2015100523253N2.